Skip to Content

News

Printer-friendly PDF version
  • June 18, 2018
    VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX-V:PAS) (Pascal), is pleased to announce significant progress in its cannabinoid based research and development program with the University of British Columbia (UBC). Pascal has been licensed by the US Drug Enforcement Administration (DEA) to conduct research and development on cannabinoids. Pascal is also pleased to renew the UBC collaboration and continue financial support of Dr. Wilfred Jefferies' laboratory at the Michael Smith Laboratories.Pascal is one of only a few organizations with a Schedule I...
  • June 5, 2018
    One look at his Twitter account (@Ng_Dave) and you know Dave’s a cool guy. With photos of science experiments, student outreach field trips, and Star Wars GIFs, Dave knows how to make science fun and accessible! A self-proclaimed “science geek” and UBC academic, Dave Ng is the Director of the Advanced Molecular Biology Laboratory (AMBL) the education and outreach facilities at Michael Smith Laboratories (MSL). He runs molecular biology workshops for professionals and science outreach programs for elementary and high-school students, so he definitely knows how to communicate science to the...
  • May 30, 2018
    VANCOUVER, British Columbia--(BUSINESS WIRE)--Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of the University of British Columbia (UBC). The company, a leading end-to-end service provider for microbiome DNA sequencing and bioinformatic analysis, has expanded into its new state-of-the-art lab in order to meet the needs of over 100 clients. “We have experienced rapid growth in our business and across the microbiome testing industry,” says CEO Malcolm Kendall. “This move is a major milestone for our company and helps us meet the needs of our growing...
  • May 28, 2018
    During this year’s spring graduation, UBC awarded ten honorary degrees for deserving individuals in various fields. Nobel Prize winner, Dr. Peter Agre, was one of the ten individuals to receive UBC’s prestigious honorary degree. Since the first degrees were awarded in 1925, recipients have included Louise Arbour, Emily Carr, His Holiness The Dalai Lama, Julie Payette, Bill Reid, David Suzuki, and many others.Click here to view awarding of Honorary Degree to Dr. Agre.  Dr. Agre is a physician and molecular biologist at Johns Hopkins University, a Bloomberg Distinguished Professor, and the...
  • April 17, 2018
    VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp. (RBSC), a leading global yeast technology company, is pleased to announce a new partnership with Mitacs for a multi-year, $1.44-million research and development project. Mitacs, a national not-for-profit research and training organization, will provide matching funding to the RBSC project to support the development of next-generation, systematic tools and methods for expanding, screening and selecting biodiversity in non-GMO industrial yeast strains.In addition to the work done directly by RBSC, the...
  • April 12, 2018
    LONDON, ON, April 12, 2018 /CNW/ - On Thursday, April 12th, six renowned medical pioneers will be recognized as the 2018 Canadian Medical Hall of Fame Inductees at a special ceremony, hosted in partnership with the Schulich School of Medicine & Dentistry, Western University, including London's own Dr. Vladimir Hachinski, one of the world's leading neurologists who has changed survival odds for stroke sufferers everywhere.Canadian Medical Hall of Fame (CMHF) Inductees are individuals whose contributions have led to extraordinary improvements in human health. Their work may be a single...
  • April 11, 2018
    Blood platelets have one main job: Stop bleeding by forming clots. Sometimes, however, these tiny cell fragments fail when they are needed most – when a person is experiencing massive bleeding, usually due to trauma.A University of British Columbia bioengineer has developed a potential strategy for endowing platelets with extra powers so they can rise to the occasion and continue coagulation. If it’s proven to work in clinical situations, such “superplatelets” might become a standard part of emergency department supplies, along with bandages, oxygen and saline.“Coagulation, which depends on a...
  • March 19, 2018
    Researchers at the University of British Columbia have shed new light on how mountain pine beetles produce an important pheromone called trans-verbenol, which could aid in efforts to better predict outbreaks.In recent years, mountain pine beetles have destroyed more than 25 million hectares of pine forests in western North America. In a study published today in Proceedings of the National Academy of Sciences, scientists have uncovered previously unknown reservoirs of trans-verbenol in the bodies of juvenile mountain pine beetles.“Trans-verbenol is a pheromone that female mountain pine beetles...
  • March 15, 2018
    One year ago, Paula Littlejohn, made a difficult decision to transition from a decade long career in the pharmaceutical industry, to a full time PhD student under Dr. Brett Finlay. As hard as career path decisions are to make for most people, Paula has done so with the consideration that she and her husband have five children. Prepare to be impressed and empowered as Paula eloquently dances through the realities of being a working mother with young children. She gives examples of her husband nearly running out of frozen breast milk while her flight is delayed in transit when returning...
  • March 13, 2018
    Under DARPA’s Pandemic Prevention Platform (P3) program, AbCellera will apply its state-of-the art capabilities in human antibody discovery and immune profiling to establish rapid countermeasures for viral pandemicsVancouver, Canada (March 13, 2018) - AbCellera Biologics Inc. announced today that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop rapid countermeasures against viral outbreaks. Over the four-year contract, AbCellera will receive up to USD $30 million in funding to establish an end-to-end platform for rapid pandemic response, and will...
Syndicate content